Across Derbyshire COVID-19 Hot/Red sites are being developed to assess patients with suspected coronavirus symptoms.
Hot/Red site principles:
A ‘HOT/RED’ site can be defined as a location(s) where patients can be seen who:
cannot be excluded from having COVID-19 and have respiratory symptoms
all patients need to be triaged by a senior GP at their practice; and 111 can redirect back to their own practice to make an appointment at the Hub - no 111 directly bookable appointments
do not need to be admitted directly, but clinician assess that they require further clinical assessment; these patients may call the practices after being directed to by 111 after assessment through this service
no patients in the shielded group can be seen here
patients must be ambulatory and full attention to strict infection control measures must be taken
Responsibility for meeting the standards lies with the site owner through the responsible person. If the site is owned by a ‘body corporate’ the directors must assure themselves that the standards are being met.
Medicines Management Framework has been compiled to support the development of
the Primary Care COVID-19 Hot/Red Site Protocol.
|Framework||Last Updated||Review Date|
|Derby and Derbyshire Medicines Management COVID-19 Red Site Framework||April 2020||March 2022|
This document is a guide for COVID hot sites, accepting that individual sites will apply their locally agreed specific principles. This document uses the most up to date information available for sharing with clinicians, but it must be noted that it is not an evidence based protocol, and therefore clinicians should use their clinical judgement when seeing patients and their skills/experience.
The key aim of the service is to deliver home visits by suitably qualified and equipped clinicians to patients deemed urgent and truly housebound, meaning they cannot attend the Red Hub Clinic.
Remote Vital Signs Service supports remote consultations in Primary Care. This is a service to support clinical decision making during the COVID-19 pandemic 2020. The aim is to manage patients at home (including care homes) where possible, reducing direct patient contact and thereby infection risk, and unnecessary hospital admission.
This document outlines deployment process based on current understanding for TPP and EMIS Electronic Prescription Service (EPS).
Red Hub Patient Specific Template COVID-19 Assessment Form
Health care professionals are responsible for the prescribing and dispensing/supply and/or administration of medicines the process needs to be underpinned by a risk assessment. There also needs to be an audit trail and clear processes in place to limit errors.
Checklist for the safe use of medicines in a community setting
For stock transferring to a different destination
To record medication received on-site
To record a weekly stock balance of medication and to audit expiry date checking
To record transfer of medication for disposal
To record daily room/storage area temperature readings where medication is being kept
Red Hub guide when seeing patients with diabetes (info for PCN CDs)
Printable protocols to attach to blood glucose and ketone meters
Specialised Pharmacy Services (SPS) Q&A on Patient Specific Directions (PSD). It includes the definition, examples of PSDs, what is not a PSD and commonly asked questions.
Produced by the Royal Pharmaceutical Society (RPS) provides guidance to pharmacists and pharmacy technicians to assist with difficult decisions being made in the exceptional circumstance presented by COVID-19. It contains guidance on structured decision making and more specific examples relevant to the current pandemic.
The Royal College of Nursing (RCN), Royal Pharmaceutical Society (RPS) and Specialist Pharmacy Service (SPS) position statement on prescribing, dispensing, supplying and administration of medicines
Royal Pharmaceutical Society (RPS) professional guidance covering areas such as the storage, transportation and disposal of medicines
Co-produced by the Royal Pharmaceutical Society (RPS) and Royal College of Nursing (RCN) provides principle-based guidance to ensure the safe administration of medicines by healthcare professionals
Health Education England (HEE) guidance covering education and training, safety critical medications, administration of medicines via alternative routes, governance and assurance
CQC is the independent regulator of health and adult social care in England. Their role is to make sure health and social care services provide people with safe, effective, compassionate, high-quality care and to encourage care services to improve
MHRA regulates medicines, medical devices and blood components for transfusion in the UK. Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development